Antithymocyte globulin induction therapy in heart transplantation: Prospective randomized study of high vs standard dosage

Transplantation Proceedings

Volumn 42, Issue 9, 2010, Pages 3679-3687

  Faggian, G ^a   Forni, A ^a   Milano, A D ^a   Chiominto, B ^a   Walpoth, B H ^b   Scarabelli, T ^c   Mazzucco, A ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CEFTAZIDIME; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PIPERACILLIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBIOTIC THERAPY; AORTA VALVE DISEASE; ARTICLE; B CELL LYMPHOMA; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CARDIOMEGALY; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEATH; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INTRAOPERATIVE PERIOD; ISCHEMIC HEART DISEASE; KIDNEY CARCINOMA; LEUKOPENIA; LUNG TUMOR; MALE; NEPHRECTOMY; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SINGLE DRUG DOSE; THROMBOCYTOPENIA; THYROID CANCER; THYROIDECTOMY;

ACUTE DISEASE; ADULT; ANTILYMPHOCYTE SERUM; CHRONIC DISEASE; COMMUNICABLE DISEASES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRAOPERATIVE CARE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 78649465610     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.06.036     Document Type: Article

References (38)

1. F.M. Hoffman Outcomes and complications after heart transplantation: a review J Cardiovasc Nurs 20 2005 S31
2. D.O. Taylor, L.B. Edwards, and M.M. Boucek Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Heart Transplant Report2005 J Heart Lung Transplant 24 2005 945
3. A. Zuckermann, and W. Klepetko Use of cyclosporine in thoracic transplantation Transplant Proc 36 2004 331S
4. W.O. Bechstein, J. Malaise, and F. Saudek Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial Transplantation 77 2004 1221
5. L.S. De Santo, G. Romano, and C. Mastroianni Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy Transplant Proc 37 2005 2684
6. D. Ducloux, A. Kazory, and B. Challier Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study Transplantation 77 2004 1029
7. L. Martins, I. Fonseca, and M. Almeida Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival Transplant Proc 37 2005 2755
8. A.R. Mueller, A. Pascher, and K.P. Platz Immunosuppression following intestinal transplantation Transplant Proc 36 2004 325
9. B. Schnetzler, P. Leger, and A. Volp A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients Transpl Int 15 2002 317
10. Z. Varghese, M.N. Abudher, and O.N. Fernando Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients Transplant Proc 33 2001 2251
11. J. Kaden, G. May, and C. Schonemann Effect of ATG prophylaxis in sensitized and non-sensitized kidney graft recipients Transpl Int 5 suppl 1 1992 S75
12. J. Kaden Eleven years intraoperative ATG bolus: a list of successes Ann Transplant 7 2002 4
13. D. Cantarovich, M. Giral-Classe, and M. Hourmant Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation Nephrol Dial Transplant 15 2000 1673
14. M. Cantarovich, N. Giannetti, and J. Barkun Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction Transplantation 78 2004 779
15. J. Carlsen, M. Johansen, and S. Boesgaard Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection J Heart Lung Transplant 24 2005 296
16. M.R. Mehra, M.J. Zucker, and L. Wagoner A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation J Heart Lung Transplant 24 2005 1297
17. J. Theodorakis, H. Schneeberger, and W.D. Illner Nephrotoxicity-free, mycophenolate mofetil-based induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors Transplant Proc 32 2000 9S
18. M.E. Billingham, N.R. Cary, M.E. Hammond Heart Rejection Study Group, International Society for Heart Transplantation A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection J Heart Transplant 9 1990 587
19. M.R. Costanzo, D.C. Naftel, and M.R. Pritzker Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors Cardiac Transplant Research Database J Heart Lung Transplant 17 1998 744
20. H. Treede, W. Klepetko, and H. Reichenspurner Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols J Heart Lung Transplant 20 2001 511
21. L.S. De Santo, C.A. Della, and G. Romano Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation Transplant Proc 36 2004 631
22. K. Krogsgaard, S. Boesgaard, and J. Aldershvile Copenhagen Heart Transplant Group: Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy Scand J Infect Dis 26 1994 239
23. A.O. Zuckermann, M. Grimm, and M. Czerny Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines Transplantation 69 2000 1890
24. A. Kawaguchi, S. Szentpetery, and T. Mohanakumar Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine J Heart Transplant 6 1987 214
25. R.L. Kormos, D.B. Herlan, and J.M. Armitage Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation J Heart Transplant 9 1990 1
26. S.A. Hunt, and F. Haddad The changing face of heart transplantation J Am Coll Cardiol 52 2008 587
27. J.D. Christic, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report2009 J Heart Lung Transplant 28 2009 1031
28. A. Beiras-Fernandez, D. Chappel, and E. Thein Impact of small variations of ischemia time after polyclonal antithymocyte globulins in a nonhuman primate model of ischemia-reperfusion injury Transplant Proc 36 2004 2579
29. A. Beiras-Fernandez, S. Walther, and E. Thein Influence of polyclonal ATGs on expression of adhesion molecules: an experimental study Transplant Proc 37 2005 1944
30. A. Beiras-Fernandez, E. Thein, and D. Chappel Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model Transpl Int 17 2004 453
31. L. Fang, B. Fehse, and M. Engel Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells Transplantation 79 2005 369
32. M.N. Abudher, J.F. Moorhead, and O.N. Fernando Preoperative ATG bolus treatment increases CsA sensitivity of peripheral blood lymphocytes (PBLS) in renal transplant patients Transplant Proc 31 1999 3361
33. C. Morath, M. Mueller, and H. Goldschmidt Malignancy in renal transplantation J Am Soc Nephrol 15 2004 1582
34. H.A. Bock, H. Gallati, and R.M. Zurcher A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation Transplantation 59 1995 830
35. G. Opelz, B. Dohler, and A. Ruhenstroth Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2004 928
36. B.K. Shenton, M.D. White, and A.E. Bell The paradox of ATG monitoring in renal transplantation Transplant Proc 26 1994 3177
37. G. Opelz, and B. Dohler Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2004 222
38. L.J. Swinnen, M.R. Costanzo-Nordin, and S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 1990 1723